148 related articles for article (PubMed ID: 9489520)
1. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome.
Rees JH
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148-9. PubMed ID: 9489520
[No Abstract] [Full Text] [Related]
2. Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute Guillain-Barré syndrome?
Weinstein R
J Clin Apher; 1995; 10(3):150-7. PubMed ID: 8582898
[No Abstract] [Full Text] [Related]
3. Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function.
Créange A; Bélec L; Clair B; Degos JD; Raphaël JC; Gherardi RK
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):162-5. PubMed ID: 9489524
[TBL] [Abstract][Full Text] [Related]
4. Modulating the immune response in demyelinating diseases.
Hughes R
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148. PubMed ID: 9489519
[No Abstract] [Full Text] [Related]
5. Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group.
Visser LH; van der Meché FG; Meulstee J; van Doorn PA
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):242-4. PubMed ID: 9489539
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
Ng KK; Howard RS; Hirsch NP; Miller DH
Neurology; 1993 Dec; 43(12):2729; author reply 2730-1. PubMed ID: 8255495
[No Abstract] [Full Text] [Related]
7. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
van der Meché FG
J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):33-4. PubMed ID: 7964849
[No Abstract] [Full Text] [Related]
8. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
Kleyweg RP; van der Meché FG
J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
[TBL] [Abstract][Full Text] [Related]
9. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
van der Meché FG
Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
[No Abstract] [Full Text] [Related]
10. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
Nagappan R; Barker J
N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous immunoglobulins in Guillain-Barré syndrome].
Hidou M; Olivier J; Vivant JF
Ann Fr Anesth Reanim; 1992; 11(1):115. PubMed ID: 1443803
[No Abstract] [Full Text] [Related]
12. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
van der Meché FG; van Doorn PA; Schmitz PI
Neurology; 1993 Dec; 43(12):2730; author reply 2730-1. PubMed ID: 8255496
[No Abstract] [Full Text] [Related]
13. Guillain-Barré syndrome: the evolution of therapy.
Cornblath DR; Hughes RA
J Neurol; 1994 May; 241(6):404-5. PubMed ID: 7931438
[No Abstract] [Full Text] [Related]
14. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
Kleyweg RP; van der Meché FG; Schmitz PI
Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508
[No Abstract] [Full Text] [Related]
15. Rational therapy of Guillain-Barré syndrome.
Raphael JC; Chevret S
Lancet; 1998 Mar; 351(9104):753. PubMed ID: 9504542
[No Abstract] [Full Text] [Related]
16. Relapses in the Guillain-Barré syndrome after treatment with intravenous immune globulin or plasma exchange.
Romano JG; Rotta FT; Potter P; Rosenfeld V; Santibanez R; Rocha B; Bradley WG
Muscle Nerve; 1998 Oct; 21(10):1327-30. PubMed ID: 9736064
[TBL] [Abstract][Full Text] [Related]
17. Intravenous IgG in Guillain-Barré syndrome.
Hughes RA
BMJ; 1996 Aug; 313(7054):376-7. PubMed ID: 8761208
[No Abstract] [Full Text] [Related]
18. Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin.
Haupt WF; Rosenow F; van der Ven C; Borberg H; Pawlik G
Ther Apher; 1997 Feb; 1(1):55-7. PubMed ID: 10225782
[TBL] [Abstract][Full Text] [Related]
19. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
Hidou M; Olivier J; Vivant JF
Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
[TBL] [Abstract][Full Text] [Related]
20. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients.
Hughes RA; Hadden RD; Rees JH; Swan AV
Brain; 1998 Apr; 121 ( Pt 4)():767-9. PubMed ID: 9577400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
